Enesi Pharma hits milestone in thermostable solid-dose live vaccines development
Enesi has achieved a key milestone in development of thermostable solid-dose live vaccines against measles and rubella
Breaking News
Protagen Protein Services merges with GeneWerk
The move establishes a premier, protein and gene analytic testing service platform worldwide
Repligen plans Polymem acquisition to expand hollow fibre capabilities
The CDMO has made the acquisition to significantly expands hollow fibre membrane and module production capabilities for ...
Thermo Fisher launches next-gen mass spectrometry solutions at summit
The new systems and software tools support scientists working across a wide range of applications, from proteomics ...
Decentralised manufacturing: how outsourcing is helping to bring the personalised medicine promise to reality
Personalised medicine represents a revolution in healthcare strategies. Combining traditional clinical information with ...
Avantor acquires RIM Bio to expand single-use business into China
Avantor has acquired a China-based manufacturer of single-use bioprocess bags and assemblies for biopharmaceutical ...
Cell-based therapy specialist Solentim expands European operations
The England-based company has established a new EU entity based in Ireland to facilitate frictionless business within ...
Using ddPCR to accurately quantify AAV viral titre and integrity
Gene therapy is primed to become the next major development in medicine and bring relief to patients living with ...
Catalent acquires third facility in Belgium for pDNA manufacturing
CDMO Catalent has acquired liver disease specialist Promethera's cell therapy manufacturing subsidiary, including its ...
German CDMO to spend $84m expanding biological cGMP space
Richter-Helm BioLogics has received investment for the new multi-product biological manufacturing facility that is ...
Oncolytic viruses: the key to advancing novel therapies to market
As researchers continue to uncover and understand the enormous complexities of cancer, emerging technology and novel ...
Opportunities to scale AAV viral vector production for gene therapies
Gene therapies hold tremendous potential as a treatment modality for inherited human diseases. This emerging ...
Bispecific antibodies: an exciting new class of emerging therapeutics
Since 2015, when the first bispecific received US FDA approval, these game-changing antibodies have rocketed in ...
Thermo Fisher launches first cleanroom-compatible CO2 incubator for cell culture
Thermo Fisher has designed the cell growth incubator with in-chamber HEPA filtration, on-demand 180°C sterilisation ...
Sartorius to open manufacturing facility in Hampshire
With the Havant facility, Sartorius now has five locations in the UK, employing over 900 staff members
In Brief
Most Popular in Biotechnology
Featured Companies
Reports
